Vol. 13. Núm. 81.
Páginas 4774-4780 (Junio 2023)

Actualización
Enfermedades renales tubulointersticiales. Nefritis intersticial crónica

Tubulointerstitial kidney diseases. Chronic interstitial nephritis

C. Vega-CabreraB. Rivas BecerraG. Fernández-Juárez
Doi : https://10.1016/j.med.2023.06.002
Opciones
Resumen

La enfermedad renal intersticial comprende un grupo de trastornos que provocan inflamación intersticial asociada a daño tubular. Tradicionalmente, la nefritis intersticial se ha clasificado morfológica y clínicamente en formas agudas y crónicas. La nefritis intersticial aguda (NIA) suele inducir un rápido deterioro de la función renal, con una marcada respuesta inflamatoria intersticial caracterizada por infiltración de células mononucleares con o sin eosinófilos, edema intersticial y afectación tubular. En cambio, la nefritis intersticial crónica (NIC) sigue un curso más indolente y se caracteriza por fibrosis intersticial, atrofia tubular y, casi siempre, infiltrado intersticial de células mononucleares. La lesión tubulointersticial es clínicamente importante porque predice la función renal presente y futura.

Palabras clave
Nefritis intersticial crónica
Nefropatía por plomo
Nefropatía por analgésicos
Abstract

Interstitial kidney disease covers a group of disorders which cause interstitial inflammation associated with tubular damage. Traditionally, interstitial nephritis has been classified morphologically and clinically as either acute or chronic. Acute interstitial nephritis (AIN) usually induces rapid deterioration of kidney function, with a marked inflammatory interstitial response that is characterized by the infiltration of mononuclear cells with or without eosinophils, interstitial oedema and tubular involvement. On the other hand, chronic interstitial nephritis (CIN) follows a more indolent course, and it is characterized by interstitial fibrosis, tubular atrophy and, almost always, interstitial infiltrate of mononuclear cells. The tubulointerstitial lesion is clinically important because it is a predictor of present and future kidney function.

Keywords
Chronic interstitial nephritis
Lead nephropathy
Analgesic nephropathy

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
A.B. Fogo
202306131057349378
, M.A. Lusco, B. Najafian, C.E. Alpers.
AJKD Atlas of renal pathology: Chronic interstitial nephritis.
Am J Kidney Dis., (2017), 70 pp. e1-e2
[2]
M.A. Perazella
202306131057349379
2023061310573493710
.
Clinical approach to diagnosing acute and chronic tubulointerstitial disease.
Adv Chronic Kidney Dis., (2017), 24 pp. 57-63
[3]
H. Marumoto
2023061310573493711
, T. Sasaki, N. Tsuboi, T. Ito, M. Ishikawa, M. Ogura, et al.
Kidney disease associated with anorexia nervosa: A case series with kidney biopsies.
Kidney Med., (2020), 2 pp. 418-424
[4]
J.P. Tolins
2023061310573493712
, M.K. Hostetter, Hostetter TH:.
Hypokalemic nephropathy in the rat: Role of ammonia in chronic tubular injury.
J Clin Invest., (1987), 79 pp. 447-458
[5]
S. Suga
2023061310573493713
, M.I. Phillips, P.E. Ray, J.A. Raleigh, C.P. Vio, Y.G. Kim, et al.
Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity.
Am J Physiol Renal Physiol., (2001), 281 pp. F620-F629
[6]
J.E. Brar
2023061310573493714
2023061310573493715
, R.J. Quigg.
Complement activation in the tubulointerstitium: AKI, CKD and in between.
Kidney Int., (2014), 86 pp. 663-666
[7]
P. Cochat
2023061310573493716
2023061310573493717
, G. Rumsby.
Primary hyperoxaluria.
N Engl J Med., (2013), 369 pp. 649-658
[8]
B. Hoppe
2023061310573493718
, B.B. Beck, Milliner DS:.
The primary hyperoxalurias.
Kidney Int., (2009), 75 pp. 1264-1271
[9]
E. Leumann
2023061310573493719
2023061310573493720
, B. Hoppe.
The primary hyperoxalurias.
J Am Soc Nephrol., (2001), 12 pp. 1986-1993
[10]
E. Salido
2023061310573493721
, A.L. Pey, R. Rodríguez, V. Lorenzo.
Primary hyperoxalurias: disorders of glyoxylate detoxification.
Biochim Biophys Acta., (2012), 1822 pp. 1453-1464
[11]
N. Anzai
2023061310573493722
, Y. Kanai, H. Endou.
New insights into renal transport of urate.
Curr Opin Rheumatol., (2007), 19 pp. 151-157
[12]
A. Enomoto
2023061310573493723
, H. Kimura, A. Chairoungdua, Y. Shigeta, P. Jutabha, S.H. Cha, et al.
Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
Nature., (2002), 417 pp. 447-452
[13]
Y. Zhou
2023061310573493724
, L. Fang, L. Jiang, P. Wen, H. Cao.
Uric acid induces renal inflammation via activating tubular NF-kB signaling pathway.
[14]
N. Vadivel
2023061310573493725
, S. Trikudanathan, A.K. Singh.
Analgesic nephropathy.
Kidney Int., (2007), 72 pp. 517-520
[15]
M.E. De Broe
2023061310573493726
2023061310573493727
, M.M. Elseviers.
Analgesic nephropathy.
N Engl J Med., (1998), 338 pp. 446-452
[16]
M.E. De Broe
2023061310573493728
, M.M. Elseviers.
Over-the-counter analgesic use.
J Am Soc Nephrol., (2009), 20 pp. 2098-2103
[17]
E.B. Ekong
2023061310573493729
2023061310573493730
, B.G. Jaar, V.M. Weaver.
Lead-related nephrotoxicity: A review of the epidemiologic evidence.
Kidney Int., (2006), 70 pp. 2074-2084
[18]
W.M. Bennett
2023061310573493731
.
Lead nephropathy.
Kidney Int., (1985), 28 pp. 212-220
[19]
A.I. Sánchez-Fructuoso
2023061310573493732
, J. Blanco, M. Cano, L. Ortega, M. Arroyo, C. Fernández, et al.
Experimental lead nephropathy: Treatment with calcium disodium ethylenediaminetetraacetate.
Am J Kidney Dis., (2002), 40 pp. 59-67
[20]
E.B. Ekong
2023061310573493733
, B.G. Jaar, V.M. Weaver.
Lead-related nephrotoxicity: a review of the epidemiologic evidence.
Kidney Int., (2006), 70 pp. 2074-2080
[21]
B. Jelakovic
2023061310573493734
, Z. Dika, V.M. Arlt.
Balkan endemic nephropathy and the causative role of aristolochic acid.
Semin Nephrol., (2019), 39 pp. 284-296
[22]
F.D. Debelle
2023061310573493735
, J.-L. Vanherweghem, J.L. Nortier.
Aristolochic acid nephropathy: a worldwide problem.
Kidney Int., (2008), 74 pp. 158-169
[23]
G. Bamias
2023061310573493736
, J. Boletis.
Balkan nephropathy: evolution of our knowledge.
Am J Kidney Dis., (2008), 52 pp. 606-616
[24]
A.R. Berliner
2023061310573493737
2023061310573493738
, M. Haas, M.J. Choi.
Sarcoidosis: the nephrologists perspective.
Am J Kidney Dis., (2006), 48 pp. 856-870
[25]
S. Maripuri
2023061310573493739
2023061310573493740
, J.P. Grande, T.G. Osborn, F.C. Fervenza, E.L. Matteson, J.V. Donadio, et al.
Renal involvement in primary sjögren syndrome: A clinicopathologic study.
Clin J Am Soc Nephrol., (2009), 4 pp. 1423-1431
[26]
N. Bossini
2023061310573493741
2023061310573493742
, S. Savoldi, F. Franceschini, S. Mombelloni, M. Baronio, I. Cavazzana, et al.
Clinical and morphological features of kidney involvement in primary Sjögrens syndrome.
Nephrol Dial Transplant., (2001), 16 pp. 2328-2336
[27]
K.K. Pun
2023061310573493743
2023061310573493744
, C.K. Wong, E.Y. Tsui, S.C. Tam, A.W. Kung, C.C. Wang.
Hypokalemic periodic paralysis due to the Sjögren syndrome in Chinese patients.
Ann Intern Med., (1989), 110 pp. 405-406
[28]
R. Correa-Rotter
2023061310573493745
2023061310573493746
, R. García-Trabanino.
Mesoamerican nephropathy.
Semin Nephrol., (2019), 39 pp. 263-271
[29]
R. Herrera Valdés
2023061310573493747
, M. Almaguer López, C.M. Orantes Navarro, L. López Marín, E.G. Brizuela Díaz, H. Bayarre Vea, et al.
Chronic interstitial nephritis of nontraditional causes in Salvadoran agricultural communities.
Clin Nephrol., (2020), 93 pp. 60-67